Terms: = Cervical cancer AND MUC1, PEM, 4582, ENSG00000185499, PUM, MAM6, EMA, CD227, H23AG
109 results:
1. muc1 promotes cervical squamous cell carcinoma through ERK phosphorylation-mediated regulation of ITGA2/ITGA3.
Zhao A; Pan Y; Gao Y; Zhi Z; Lu H; Dong B; Zhang X; Wu M; Zhu F; Zhou S; Ma S
BMC Cancer; 2024 May; 24(1):559. PubMed ID: 38702644
[TBL] [Abstract] [Full Text] [Related]
2. Anaplastic large cell lymphoma presenting as a mass in the uterine cervix: a case report.
Mingola P; Alshomrani A; Greiner T
J Hematop; 2024 Mar; 17(1):23-26. PubMed ID: 38376721
[TBL] [Abstract] [Full Text] [Related]
3. Validation of an on-chip p16
Hashimoto K; Kumagai T; Nomura K; Miyagawa Y; Tago S; Takasaki K; Takahashi Y; Nishida H; Ichinose T; Hirano M; Hiraike H; Wada-Hiraike O; Sasajima Y; Kim SH; Nagasaka K
Sci Rep; 2023 Oct; 13(1):17052. PubMed ID: 37816765
[TBL] [Abstract] [Full Text] [Related]
4. Clinical Value Analysis of Serum TK1, SCC-Ag, and MUC-1 in the Diagnosis and Prognosis Evaluation of cervical cancer.
Zhang M; Xin L; Cheng B; Yan B; Zhen J; Yang C; Ma L; Hou Q
Altern Ther Health Med; 2023 Nov; 29(8):788-792. PubMed ID: 37708549
[TBL] [Abstract] [Full Text] [Related]
5. In what ways does user experience design improve printed educational materials?
Kealey MR; Urakami J; Henderson K; Chignell M; Straus SE
Appl Ergon; 2023 Nov; 113():104081. PubMed ID: 37393832
[TBL] [Abstract] [Full Text] [Related]
6. Association of Sialyl Tn antigen with cervical cancer lymph node status: An NRG oncology/GOG study.
Benbrook DM; Deng W; Gold MA; Rai R; Conrad R; van der Wel H; Husain S; Moore K; Spirtos N; Jackson AL; Zakhour M; Mathews CA; West CM
Gynecol Oncol; 2023 Apr; 171():67-75. PubMed ID: 36827840
[TBL] [Abstract] [Full Text] [Related]
7. Investigating the relationship between the cervical mucoprotein levels and cervical intraepithelial neoplasia.
Kulaksiz D; Bayoglu Tekin Y; Deger O; Baki Erin K
Minerva Obstet Gynecol; 2023 Dec; 75(6):559-564. PubMed ID: 35785924
[TBL] [Abstract] [Full Text] [Related]
8. The study of clinicopathologic features of cervical squamous carcinoma with invasive micropapillary like pattern and phenotype.
Wang H; Yang K; Li Q; Su W; Liu X; Feng K; Song H; Li S; Jiang H
Histol Histopathol; 2022 Sep; 37(9):853-861. PubMed ID: 35510512
[TBL] [Abstract] [Full Text] [Related]
9. Antibodies as biomarkers for cancer risk: a systematic review.
Monroy-Iglesias MJ; Crescioli S; Beckmann K; Le N; Karagiannis SN; Van Hemelrijck M; Santaolalla A
Clin Exp Immunol; 2022 Jul; 209(1):46-63. PubMed ID: 35380164
[TBL] [Abstract] [Full Text] [Related]
10. Peptides for Vaccine Development.
Hamley IW
ACS Appl Bio Mater; 2022 Mar; 5(3):905-944. PubMed ID: 35195008
[TBL] [Abstract] [Full Text] [Related]
11. Newly diagnosed follicular lymphoma during pembrolizumab treatment for lung cancer.
Marumo Y; Kusumoto S; Masaki A; Nakashima T; Kikuchi T; Mori F; Komatsu H; Inagaki H; Iida S; Inagaki A
Int J Hematol; 2021 Aug; 114(2):280-285. PubMed ID: 33772730
[TBL] [Abstract] [Full Text] [Related]
12. Primary Synovial Sarcoma of the Uterine Cervix: First Case Report.
Vaziri Fard E; Zhang S; El Achi HS; Covinsky M
Int J Gynecol Pathol; 2021 Mar; 40(2):196-203. PubMed ID: 33075021
[TBL] [Abstract] [Full Text] [Related]
13. Elevation of microRNA-512-5p inhibits muc1 to reduce radioresistance in cervical cancer.
Zhang J; Wang L; Jiang J; Qiao Z
Cell Cycle; 2020 Mar; 19(6):652-665. PubMed ID: 32126879
[TBL] [Abstract] [Full Text] [Related]
14. EP3 receptor is a prognostic factor in TA-muc1-negative ovarian cancer.
Czogalla B; Kuhn C; Heublein S; Schmöckel E; Mayr D; Kolben T; Trillsch F; Burges A; Mahner S; Jeschke U; Hester A
J Cancer Res Clin Oncol; 2019 Oct; 145(10):2519-2527. PubMed ID: 31485769
[TBL] [Abstract] [Full Text] [Related]
15. MYCN amplification drives an aggressive form of spinal ependymoma.
Ghasemi DR; Sill M; Okonechnikov K; Korshunov A; Yip S; Schutz PW; Scheie D; Kruse A; Harter PN; Kastelan M; Wagner M; Hartmann C; Benzel J; Maass KK; Khasraw M; Sträter R; Thomas C; Paulus W; Kratz CP; Witt H; Kawauchi D; Herold-Mende C; Sahm F; Brandner S; Kool M; Jones DTW; von Deimling A; Pfister SM; Reuss DE; Pajtler KW
Acta Neuropathol; 2019 Dec; 138(6):1075-1089. PubMed ID: 31414211
[TBL] [Abstract] [Full Text] [Related]
16. Serum CA153 as biomarker for cancer and noncancer diseases.
Li X; Xu Y; Zhang L
Prog Mol Biol Transl Sci; 2019; 162():265-276. PubMed ID: 30905456
[TBL] [Abstract] [Full Text] [Related]
17. TA-muc1 as detected by the fully humanized, therapeutic antibody Gatipotzumab predicts poor prognosis in cervical cancer.
Heublein S; Friese K; Kost B; Marmé F; Kuhn C; Mahner S; Dannecker C; Mayr D; Jeschke U; Vattai A
J Cancer Res Clin Oncol; 2018 Oct; 144(10):1899-1907. PubMed ID: 30062487
[TBL] [Abstract] [Full Text] [Related]
18. SMARCA4-deficient undifferentiated uterine sarcoma (malignant rhabdoid tumor of the uterus): a clinicopathologic entity distinct from undifferentiated carcinoma.
Kolin DL; Dong F; Baltay M; Lindeman N; MacConaill L; Nucci MR; Crum CP; Howitt BE
Mod Pathol; 2018 Sep; 31(9):1442-1456. PubMed ID: 29700418
[TBL] [Abstract] [Full Text] [Related]
19. Rapid nodal staging of head and neck cancer surgical specimens with flow cytometric analysis.
Häyry V; Kågedal Å; Hjalmarsson E; Neves da Silva PF; Drakskog C; Margolin G; Georén SK; Munck-Wikland E; Winqvist O; Cardell LO
Br J Cancer; 2018 Feb; 118(3):421-427. PubMed ID: 29161240
[TBL] [Abstract] [Full Text] [Related]
20. Potential impact of a nonavalent HPV vaccine on HPV related low-and high-grade cervical intraepithelial lesions: A referral hospital-based study in Sicily.
Capra G; Giovannelli L; Matranga D; Bellavia C; Guarneri MF; Fasciana T; Scaduto G; Firenze A; Vassiliadis A; Perino A
Hum Vaccin Immunother; 2017 Aug; 13(8):1839-1843. PubMed ID: 28594305
[TBL] [Abstract] [Full Text] [Related]
[Next]
